# A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese Adults

> **NCT04306302** · PHASE1 · COMPLETED · sponsor: **Janssen Pharmaceutical K.K.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** ExPEC10V
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04306302
- **Lead sponsor:** Janssen Pharmaceutical K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-13
- **Primary completion:** 2020-12-24
- **Final completion:** 2020-12-24
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04306302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04306302, "A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04306302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*